Discussions with regulators and procurers suggest these agencies may have ignored many similar incidents during India's COVID-19 epidemic.

Government drug labs in at least seven states and one union territory have either not conducted impurity tests ever or haven’t performed them as a matter of routine; doing this endangers patient health and distorts official estimates of the rates of substandard drugs in India.

India's newly launched programme to widely and rapidly sequence genomes of the novel coronavirus has already run into major hurdles.

Medical certificate of cause of death is an important document; however, it is routinely denied by the hospitals across the country to the families of the deceased even after repeated requests.

Worrying discrepancies have emerged between the claims made by Biocon’s chief medical officer Sandeep Athalye at a press conference on July 13 and how the trial was actually conducted.

Telangana may not be reported as many as 50% of its total COVID-19 deaths in their official numbers.